These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 35622436)

  • 1. Acylcarnitines and Genetic Variation in Fat Oxidation Genes in HIV-infected, Antiretroviral-treated Children With and Without Myopathy.
    Kirmse B; Hobbs C; Aaron L; Montepiedra G; Summar M; Williams PL; Smith CJ; Van Dyke R; Yu C; Ryckman KK; Borkowsky W;
    Pediatr Infect Dis J; 2022 Aug; 41(8):e306-e311. PubMed ID: 35622436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acylcarnitine Profiles in HIV-Exposed, Uninfected Neonates in the United States.
    Kirmse B; Yao TJ; Hofherr S; Kacanek D; Williams PL; Hobbs CV; Hazra R; Borkowsky W; Van Dyke RB; Summar M
    AIDS Res Hum Retroviruses; 2016 Apr; 32(4):339-48. PubMed ID: 26548585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal newborn screens and acylcarnitines in HIV-exposed and ARV-exposed infants.
    Kirmse B; Hobbs CV; Peter I; Laplante B; Caggana M; Kloke K; Raymond K; Summar M; Borkowsky W
    Pediatr Infect Dis J; 2013 Feb; 32(2):146-50. PubMed ID: 22935866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Slc22a5 haploinsufficiency does not aggravate the phenotype of the long-chain acyl-CoA dehydrogenase KO mouse.
    Ranea-Robles P; Yu C; van Vlies N; Vaz FM; Houten SM
    J Inherit Metab Dis; 2020 May; 43(3):486-495. PubMed ID: 31845336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiretroviral therapy affects the composition of weight loss in HIV infection: implications for clinical nutrition.
    Maia BS; Engelson ES; Wang J; Kotler DP
    Clin Nutr; 2005 Dec; 24(6):971-8. PubMed ID: 16095765
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiretroviral exposure and lymphocyte mtDNA content among uninfected infants of HIV-1-infected women.
    Aldrovandi GM; Chu C; Shearer WT; Li D; Walter J; Thompson B; McIntosh K; Foca M; Meyer WA; Ha BF; Rich KC; Moye J
    Pediatrics; 2009 Dec; 124(6):e1189-97. PubMed ID: 19933732
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dual nucleoside reverse transcriptase inhibitor therapy in the combination antiretroviral therapy era and predictors of discontinuation or switch to combination antiretroviral therapy.
    Selinger-Leneman H; Matheron S; Mahamat A; Moreau J; Costagliola D; Abgrall S;
    J Acquir Immune Defic Syndr; 2008 Feb; 47(2):206-11. PubMed ID: 17971717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteopenia in HIV-infected men: association with asymptomatic lactic acidemia and lower weight pre-antiretroviral therapy.
    Carr A; Miller J; Eisman JA; Cooper DA
    AIDS; 2001 Apr; 15(6):703-9. PubMed ID: 11371684
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A review of the toxicity of HIV medications.
    Margolis AM; Heverling H; Pham PA; Stolbach A
    J Med Toxicol; 2014 Mar; 10(1):26-39. PubMed ID: 23963694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Initial therapy with nucleoside reverse transcriptase inhibitor-containing regimens is more effective than with regimens that spare them with no difference in short-term fat distribution: Hippocampe-ANRS 121 Trial.
    Duvivier C; Ghosn J; Assoumou L; Soulié C; Peytavin G; Calvez V; Génin MA; Molina JM; Bouchaud O; Katlama C; Costagliola D;
    J Antimicrob Chemother; 2008 Oct; 62(4):797-808. PubMed ID: 18641035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV and mitochondrial toxicity in children.
    Foster C; Lyall H
    J Antimicrob Chemother; 2008 Jan; 61(1):8-12. PubMed ID: 17999978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of drug-resistance mutations in HIV type 1 isolates from drug-naive and ARV-treated patients in Bulgaria.
    Santoro MM; Ciccozzi M; Alteri C; Montieri S; Alexiev I; Dimova I; Ceccherini-Silberstein F; Beshkov D; Rezza G; Perno CF
    AIDS Res Hum Retroviruses; 2008 Sep; 24(9):1133-8. PubMed ID: 18788909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Geographic and temporal trends in the molecular epidemiology and genetic mechanisms of transmitted HIV-1 drug resistance: an individual-patient- and sequence-level meta-analysis.
    Rhee SY; Blanco JL; Jordan MR; Taylor J; Lemey P; Varghese V; Hamers RL; Bertagnolio S; Rinke de Wit TF; Aghokeng AF; Albert J; Avi R; Avila-Rios S; Bessong PO; Brooks JI; Boucher CA; Brumme ZL; Busch MP; Bussmann H; Chaix ML; Chin BS; D'Aquin TT; De Gascun CF; Derache A; Descamps D; Deshpande AK; Djoko CF; Eshleman SH; Fleury H; Frange P; Fujisaki S; Harrigan PR; Hattori J; Holguin A; Hunt GM; Ichimura H; Kaleebu P; Katzenstein D; Kiertiburanakul S; Kim JH; Kim SS; Li Y; Lutsar I; Morris L; Ndembi N; Ng KP; Paranjape RS; Peeters M; Poljak M; Price MA; Ragonnet-Cronin ML; Reyes-Terán G; Rolland M; Sirivichayakul S; Smith DM; Soares MA; Soriano VV; Ssemwanga D; Stanojevic M; Stefani MA; Sugiura W; Sungkanuparph S; Tanuri A; Tee KK; Truong HM; van de Vijver DA; Vidal N; Yang C; Yang R; Yebra G; Ioannidis JP; Vandamme AM; Shafer RW
    PLoS Med; 2015 Apr; 12(4):e1001810. PubMed ID: 25849352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered fat distribution in HIV-positive men on nucleoside analog reverse transcriptase inhibitor therapy.
    Mulligan K; Tai VW; Algren H; Abrams DI; Leiser RJ; Lo JC; Schambelan M
    J Acquir Immune Defic Syndr; 2001 Apr; 26(5):443-8. PubMed ID: 11391163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Burden of Exposure to Potential Interactions Between Antiretroviral and Non-Antiretroviral Medications in a Population of HIV-Positive Patients Aged 50 Years or Older.
    Ranzani A; Oreni L; Agrò M; van den Bogaart L; Milazzo L; Giacomelli A; Cattaneo D; Gervasoni C; Ridolfo AL
    J Acquir Immune Defic Syndr; 2018 Jun; 78(2):193-201. PubMed ID: 29767640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Redistribution of body fat in HIV-infected women undergoing combined antiretroviral therapy.
    Gervasoni C; Ridolfo AL; Trifirò G; Santambrogio S; Norbiato G; Musicco M; Clerici M; Galli M; Moroni M
    AIDS; 1999 Mar; 13(4):465-71. PubMed ID: 10197374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regimen selection in the OPTIONS trial of HIV salvage therapy: drug resistance, prior therapy, and race-ethnicity determine the degree of regimen complexity.
    Tashima KT; Mollan KR; Na L; Gandhi RT; Klingman KL; Fichtenbaum CJ; Andrade A; Johnson VA; Eron JJ; Smeaton L; Haubrich RH
    HIV Clin Trials; 2015 Aug; 16(4):147-56. PubMed ID: 26212575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Newborn screening for primary carnitine deficiency and variant spectrum of SLC22A5 gene in Guangzhou].
    Huang YL; Tang CF; Liu SC; Sheng HY; Tang F; Jiang X; Zheng RD; Mei HF; Liu L
    Zhonghua Er Ke Za Zhi; 2020 Jun; 58(6):476-481. PubMed ID: 32521959
    [No Abstract]   [Full Text] [Related]  

  • 19. Low serum carnitine in HIV-infected children on antiretroviral treatment.
    Vilaseca MA; Artuch R; Sierra C; Pineda J; López-Vilches MA; Muñoz-Almagro C; Fortuny C
    Eur J Clin Nutr; 2003 Oct; 57(10):1317-22. PubMed ID: 14506495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Superior Glucose Tolerance and Metabolomic Profiles, Independent of Adiposity, in HIV-Infected Women Compared With Men on Antiretroviral Therapy.
    Koethe JR; Jenkins CA; Petucci C; Culver J; Shepherd BE; Sterling TR
    Medicine (Baltimore); 2016 May; 95(19):e3634. PubMed ID: 27175676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.